Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

604 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml.
Ferro M, Bruzzese D, Perdonà S, Marino A, Mazzarella C, Perruolo G, D'Esposito V, Cosimato V, Buonerba C, Di Lorenzo G, Musi G, De Cobelli O, Chun FK, Terracciano D. Ferro M, et al. Among authors: chun fk. PLoS One. 2013 Jul 4;8(7):e67687. doi: 10.1371/journal.pone.0067687. Print 2013. PLoS One. 2013. PMID: 23861782 Free PMC article.
Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay.
Hansen J, Auprich M, Ahyai SA, de la Taille A, van Poppel H, Marberger M, Stenzl A, Mulders PF, Huland H, Fisch M, Abbou CC, Schalken JA, Fradet Y, Marks LS, Ellis W, Partin AW, Pummer K, Graefen M, Haese A, Walz J, Briganti A, Shariat SF, Chun FK. Hansen J, et al. Among authors: chun fk. Eur Urol. 2013 Feb;63(2):201-9. doi: 10.1016/j.eururo.2012.07.030. Epub 2012 Jul 20. Eur Urol. 2013. PMID: 22854248
Improving the stratification of intermediate risk prostate cancer.
Nocera L, Collà Ruvolo C, Stolzenbach LF, Deuker M, Tian Z, Gandaglia G, Fossati N, Abdollah F, Suardi N, Mirone V, Graefen M, Chun FK, Saad F, Montorsi F, Briganti A, Karakiewicz PI. Nocera L, et al. Among authors: chun fk. Minerva Urol Nephrol. 2022 Oct;74(5):590-598. doi: 10.23736/S2724-6051.21.04314-7. Epub 2021 Apr 22. Minerva Urol Nephrol. 2022. PMID: 33887893 Free article.
Regional differences in stage distribution and rates of treatment for adrenocortical carcinoma across United States SEER registries.
Panunzio A, Tappero S, Piccinelli M, Cano Garcia C, Barletta F, Incesu RB, Law KW, Tian Z, Tafuri A, Saad F, Shariat SF, Tilki D, Briganti A, Chun FK, DE Cobelli O, Terrone C, Bourdeau I, Cerruto MA, Antonelli A, Karakiewicz PI. Panunzio A, et al. Among authors: chun fk. Minerva Urol Nephrol. 2023 Aug;75(4):443-451. doi: 10.23736/S2724-6051.23.05342-9. Minerva Urol Nephrol. 2023. PMID: 37530661 Free article.
Validation of lymphovascular invasion as a predictor of lymph-node invasion in squamous cell carcinoma of the penis.
Jannello LM, DE Angelis M, Siech C, DI Bello F, Rodriguez Peñaranda N, Tian Z, Goyal JA, Luzzago S, Mistretta FA, Tozzi M, Saad F, Chun FK, Briganti A, Puliatti S, Longo N, DE Cobelli O, Musi G, Karakiewicz PI. Jannello LM, et al. Among authors: chun fk. Minerva Urol Nephrol. 2024 Nov 4. doi: 10.23736/S2724-6051.24.05938-X. Online ahead of print. Minerva Urol Nephrol. 2024. PMID: 39494945
604 results